# Renalytix plc (RNLX)

Source: https://www.quantisnow.com/company/RNLX
Generated: 2026-11-20T12:29:21.397Z

- Ticker: RNLX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2020
- Website: renalytix.com

## About

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record, and systems to generate a unique patient risk score. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was founded in 2018 and is based in London, the United Kingdom.

## Latest RNLX news and filings

- 2024-10-11 20:36 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-renalytix-plc-5723624)
- 2024-10-08 11:00 UTC [Commencement of trading on OTCQB in the United States](https://www.quantisnow.com/insight/commencement-of-trading-on-otcqb-in-the-united-states-5718995)
- 2024-10-03 00:05 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Renalytix plc](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-renalytix-plc-5714029)
- 2024-10-01 21:14 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-renalytix-plc-5711001)
- 2024-10-01 21:12 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Results of Operations and Financial Condition, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-results-of-operations-and-5710979)
- 2024-09-30 18:48 UTC [SEC Form 10-K] [SEC Form 10-K filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-renalytix-plc-5708327)
- 2024-08-27 11:00 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-notice-of-delisting-or-5672619)
- 2024-07-15 11:30 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-unregistered-sales-of-equity-5607290)
- 2024-07-12 17:42 UTC [Market Chatter] [HC Wainwright & Co. Reiterates Buy on Renalytix, Maintains $3 Price Target](https://www.quantisnow.com/insight/hc-wainwright-co-reiterates-buy-on-renalytix-maintains-3-price-5606141)
- 2024-07-12 17:15 UTC [Market Insight] [Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session](https://www.quantisnow.com/insight/why-asp-isotopes-shares-are-trading-lower-by-9-here-5606081)
- 2024-07-11 18:02 UTC [Market Insight] [Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-conagra-brands-shares-are-trading-lower-here-are-other-5604227)
- 2024-07-11 16:01 UTC [Market Insight] [Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales](https://www.quantisnow.com/insight/nasdaq-dips-over-300-points-pepsico-reports-weak-sales-5603993)
- 2024-07-11 11:53 UTC [Market Chatter] [Renalytix shares are trading higher after the company announced a collaboration with the Steno Diabetes Center, Copenhagen, to advance translation of precision medicine solutions for patients with Diabetes and Chronic Kidney Disease.](https://www.quantisnow.com/insight/renalytix-shares-are-trading-higher-after-the-company-announced-a-5603248)
- 2024-07-11 11:06 UTC [Market Chatter] [Renalytix Collaborates With Steno Diabetes Center, Cpenhagen, To Develop A Roadmap For Implementation Of KidneyIntelX, Marking First Expansion For KidneyIntelX Platform Beyond US](https://www.quantisnow.com/insight/renalytix-collaborates-with-steno-diabetes-center-cpenhagen-to-develop-a-5603115)
- 2024-07-11 11:00 UTC [Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US](https://www.quantisnow.com/insight/renalytix-and-steno-diabetes-center-announce-precision-medicine-collaboration-marking-5603069)
- 2024-07-01 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-renalytix-plc-5584948)
- 2024-06-28 20:26 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-renalytix-plc-5584054)
- 2024-06-28 07:07 UTC [Market Chatter] [Renalytix Fights Nasdaq Delisting with Strategic Plan, Trading Temporarily Safe](https://www.quantisnow.com/insight/renalytix-fights-nasdaq-delisting-with-strategic-plan-trading-temporarily-safe-5582225)
- 2024-06-27 22:30 UTC [Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination](https://www.quantisnow.com/insight/renalytix-submits-hearing-request-to-nasdaq-hearings-panel-in-regard-5582099)
- 2024-06-26 01:15 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by Renalytix plc](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-renalytix-plc-5577287)
- 2024-06-25 21:23 UTC [SEC Form 8-K] [Amendment: Renalytix plc filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-renalytix-plc-filed-sec-form-8-k-changes-in-registrants-5576940)
- 2024-06-24 21:15 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-notice-of-delisting-or-5574346)
- 2024-06-24 21:10 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-changes-in-registrants-certifying-5574316)
- 2024-06-17 20:30 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-regulation-fd-disclosure-financial-5562371)
- 2024-06-14 14:32 UTC [Market Chatter] [Renalytix shares are trading higher after the company announced Medicare issued a final Local Coverage Determination for its kidneyintelX.dkd testing](https://www.quantisnow.com/insight/renalytix-shares-are-trading-higher-after-the-company-announced-medicare-5558277)
- 2024-06-14 14:30 UTC [Market Chatter] [Renalytix Reported Earlier That Medicare Issued Final Kocal Coverage Determination For kidneyintelX.dkd Testing](https://www.quantisnow.com/insight/renalytix-reported-earlier-that-medicare-issued-final-kocal-coverage-determination-5558274)
- 2024-06-14 13:31 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by Renalytix plc](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-renalytix-plc-5558136)
- 2024-06-14 11:00 UTC [Medicare Issues Final Coverage Determination for kidneyintelX.dkd](https://www.quantisnow.com/insight/medicare-issues-final-coverage-determination-for-kidneyintelxdkd-5557697)
- 2024-06-13 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Interim Chief Financial Office Jung Joel R](https://www.quantisnow.com/insight/sec-form-4-filed-by-interim-chief-financial-office-jung-5556463)
- 2024-06-12 21:00 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-leadership-update-financial-statements-5554239)
- 2024-06-06 12:07 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-pre-market-session-5541203)
- 2024-06-05 20:31 UTC [SEC Form S-3] [SEC Form S-3 filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-renalytix-plc-5539766)
- 2024-06-05 20:17 UTC [SEC Form 3] [SEC Form 3 filed by new insider Jung Joel R](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-jung-joel-r-5539568)
- 2024-05-28 11:15 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-leadership-update-regulation-fd-5518481)
- 2024-05-27 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-after-market-session-5518055)
- 2024-05-15 16:11 UTC [Market Chatter] [Renalytix shares are trading lower after the company reported worse-than-expected Q3 financial results.](https://www.quantisnow.com/insight/renalytix-shares-are-trading-lower-after-the-company-reported-worse-than-expected-5492407)
- 2024-05-15 14:09 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-renalytix-plc-5492106)
- 2024-05-15 13:23 UTC [SEC Form 8-K] [Renalytix plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renalytix-plc-filed-sec-form-8-k-entry-into-a-material-5491954)
- 2024-05-15 11:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Renalytix plc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-renalytix-plc-5491220)
- 2024-05-15 11:02 UTC [Market Chatter] [Renalytix Q3 2024 GAAP EPS $(0.08) Misses $(0.07) Estimate, Sales $535.000 Miss $950.000K Estimate](https://www.quantisnow.com/insight/renalytix-q3-2024-gaap-eps-008-misses-007-estimate-sales-5491106)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RNLX
- Earnings history: https://www.quantisnow.com/earnings/RNLX
- Dividend history: https://www.quantisnow.com/dividends/RNLX
- Insider transactions: https://www.quantisnow.com/insiders/RNLX
- Options chain: https://www.quantisnow.com/options/RNLX
- SEC 8-K filings only: https://www.quantisnow.com/company/RNLX/8-k
- RSS and alerts for RNLX: https://www.quantisnow.com/docs/rss-feeds.md
